Liu S H, Hou X Y, Zhang X X, Liu G W, Xin F J, Wang J G, Zhang D L, Wang D S, Lu Y
Department of general surgery Medical center, Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Department of Health Management Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
Peripheral nerve invasion (PNI) is associated with local recurrence and poor prognosis in patients with advanced gastric cancer. A risk-assessment model based on preoperative indicators for predicting PNI of gastric cancer may help to formulate a more reasonable and accurate individualized diagnosis and treatment plan. Inclusion criteria: (1) electronic gastroscopy and enhanced CT examination of the upper abdomen were performed before surgery; (2) radical gastric cancer surgery (D2 lymph node dissection, R0 resection) was performed; (3) no distant metastasis was confirmed before and during operation; (4) postoperative pathology showed an advanced gastric cancer (T2-4aN0-3M0), and the clinical data was complete. Those who had other malignant tumors at the same time or in the past, and received neoadjuvant radiochemotherapy or immunotherapy before surgery were excluded. In this retrospective case-control study, 550 patients with advanced gastric cancer who underwent curative gastrectomy between September 2017 and June 2019 were selected from the Affiliated Hospital of Qingdao University for modeling and internal verification, including 262 (47.6%) PNI positive and 288 (52.4%) PNI negative patients. According to the same standard, clinical data of 50 patients with advanced gastric cancer who underwent radical surgery from July to November 2019 in Qingdao Municipal Hospital were selected for external verification of the model. There were no statistically significant differences between the clinical data of internal verification and external verification (all >0.05). Univariate analysis and multivariate logistic regression analysis were used to determine the independent risk factors for PNI in advanced gastric cancer, and the clinical indicators with statistically significant difference were used to establish a preoperative nomogram model through R software. The Bootstrap method was applied as internal verification to show the robustness of the model. The discrimination of the nomogram was determined by calculating the average consistency index (C-index). The calibration curve was used to evaluate the consistency of the predicted results with the actual results. The Hosmer-Lemeshow test was used to examine the goodness of fit of the discriminant model. During external verification, the corresponding C-index index was also calculated. The area under ROC curve (AUC) was used to evaluate the predictive ability of the nomogram in the internal verification and external verification groups. A total of 550 patients were identified in this study, 262 (47.6%) of which had PNI. Multivariate logistic regression analysis revealed that carcinoembryonic antigen level ≥ 5 μg/L (OR=5.870, 95% CI: 3.281-10.502, <0.001), tumor length ≥5 cm (OR=5.539,95% CI: 3.165-9.694, <0.001), mixed Lauren classification (OR=2.611, 95%CI: 1.272-5.360, =0.009), cT3 stage (OR=13.053, 95% CI: 5.612-30.361, <0.001) and the presence of lymph node metastasis (OR=4.826, 95% CI: 2.729-8.533, <0.001) were significant independent risk factors of PNI in advanced gastric cancer (all <0.05). Based on these results, diffused Lauren classification and cT4 stage were included to establish a predictive nomogram model. CEA ≥ 5 μg/L was for 68 points, tumor length ≥ 5 cm was for 67 points, mixed Lauren classification was for 21 points, diffused Lauren classification was for 38 points, cT3 stage was for 75 points, cT4 stage was for 100 points, and lymph node metastasis was for 62 points. Adding the scores of all risk factors was total score, and the probability corresponding to the total score was the probability that the model predicted PNI in advanced gastric cancer before surgery. The internal verification result revealed that the AUC of nomogram was 0.935, which was superior than that of any single variable, such as CEA, Lauren classification, cT stage, tumor length and lymph node metastasis (AUC: 0.731, 0.595, 0.838, 0.757 and 0.802, respectively). The external verification result revealed the AUC of nomogram was 0.828. The C-ndex was 0.931 after internal verification. External verification showed a C-index of 0.828 from the model. The calibration curve showed that the predictive results were good in accordance with the actual results (=0.415). A nomogram model constructed by CEA, tumor length, Lauren classification (mixed, diffuse), cT stage, and lymph node metastasis can predict the PNI of advanced gastric cancer before surgery.
周围神经侵犯(PNI)与进展期胃癌患者的局部复发及不良预后相关。基于术前指标预测胃癌PNI的风险评估模型可能有助于制定更合理、准确的个体化诊疗方案。纳入标准:(1)术前进行电子胃镜及上腹部增强CT检查;(2)行胃癌根治术(D2淋巴结清扫,R0切除);(3)术前及术中未证实有远处转移;(4)术后病理显示为进展期胃癌(T2-4aN0-3M0),且临床资料完整。排除同时或既往有其他恶性肿瘤,以及术前接受新辅助放化疗或免疫治疗者。在这项回顾性病例对照研究中,选取2017年9月至2019年6月在青岛大学附属医院接受根治性胃切除术的550例进展期胃癌患者进行建模及内部验证,其中PNI阳性患者262例(47.6%),PNI阴性患者288例(52.4%)。按照相同标准,选取2019年7月至11月在青岛市市立医院接受根治性手术的50例进展期胃癌患者的临床资料进行模型的外部验证。内部验证与外部验证的临床资料差异无统计学意义(均>0.05)。采用单因素分析和多因素logistic回归分析确定进展期胃癌PNI的独立危险因素,并将差异有统计学意义的临床指标通过R软件建立术前列线图模型。采用Bootstrap法进行内部验证以显示模型的稳健性。通过计算平均一致性指数(C指数)确定列线图的区分度。采用校准曲线评估预测结果与实际结果的一致性。采用Hosmer-Lemeshow检验检验判别模型的拟合优度。在外部验证时,也计算相应的C指数指标。采用ROC曲线下面积(AUC)评估列线图在内部验证组和外部验证组中的预测能力。本研究共纳入550例患者,其中262例(47.6%)发生PNI。多因素logistic回归分析显示,癌胚抗原水平≥5μg/L(OR=5.870,95%CI:3.281-10.502,<0.001)、肿瘤长度≥5cm(OR=5.539,95%CI:3.165-9.694,<0.001)、Lauren混合型(OR=2.611,95%CI:1.272-5.360,=0.009)、cT3期(OR=13.053,95%CI:5.612-30.361,<0.001)及有淋巴结转移(OR=4.826,95%CI:2.729-8.533,<0.001)是进展期胃癌PNI的显著独立危险因素(均<0.05)。基于这些结果,纳入弥漫型Lauren分类和cT4期建立预测列线图模型。癌胚抗原≥5μg/L计68分,肿瘤长度≥5cm计67分,Lauren混合型计21分,弥漫型Lauren分类计38分,cT3期计75分,cT4期计100分,淋巴结转移计62分。将所有危险因素得分相加即为总分,总分对应的概率即为模型术前预测进展期胃癌发生PNI的概率。内部验证结果显示,列线图的AUC为0.935,优于任何单一变量,如癌胚抗原、Lauren分类、cT分期、肿瘤长度及淋巴结转移(AUC分别为0.731、0.595、0.838、0.757及0.802)。外部验证结果显示列线图的AUC为0.828。内部验证后C指数为0.931。外部验证显示模型的C指数为0.828。校准曲线显示预测结果与实际结果吻合良好(=0.415)。由癌胚抗原、肿瘤长度、Lauren分类(混合型、弥漫型)、cT分期及淋巴结转移构建的列线图模型可在术前预测进展期胃癌的PNI。